SENSIMED Triggerfish Discomfort During IOP Monitoring

Evaluation of SENSIMED Triggerfish for 24 Hour IOP Monitoring in Healthy Subjects and Glaucoma Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00966108

Acronym

09/02

Enrollment

Registered

2009-08-26

Start date

2009-08-31

Completion date

2010-01-31

Last updated

2010-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Safety and Tolerability of SENSIMED Triggerfish in Glaucoma Patients

Brief summary

Evaluation of the wearing discomfort (safety and tolerability) involved during IOP monitoring with the SENISMED Triggerfish, a sensor embedded in a telemetric contact lens

Interventions

DEVICESENSIMED Triggerfish

Ocular Telemetry Sensor for IOP monitoring

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* Patient is able to comply with the study procedure * Patient is 18-80 years old * Healthy subject or glaucoma patient * Patient has consented to be in the trial and signed informed consent is available before any study related procedures are carried out * Cylinder refraction of no more than +/- 2 diopters in the study eye * Visual acuity of 20/80 or better in the study eye * Ability of subject to understand the character and individual consequences of the study * For women with childbearing potential, adequate contraception

Exclusion criteria

* Subjects wearing contact lenses within the last two years * Subjects with contraindications for wearing contact lenses * History of refractive surgery * History of intraocular surgery in the last three months * Severe dry eye syndrome * Keratoconus or other corneal abnormalities * Conjunctival or intraocular inflammation * Pregnancy and lactation * Simultaneous participation in other clinical trials

Design outcomes

Primary

Measure	Time frame
ocular discomfort on a visual analogue scale	24 hours

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026